Condition
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive clinical trials that are recruiting, in United States. By phase: Phase 2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using edetate calcium disodium or succimer to treat acute myeloid leukemia or myelodysplastic syndrome during chemotherapy | Phase 1 | Houston, Texas | Recruiting | Aug 15, 2018 |
| Using dexrazoxane to protect the heart during chemotherapy for blood cancers | Phase 2 | Houston, Texas | Recruiting | Jul 18, 2018 |
| Combining blinatumomab, methotrexate, cytarabine, and ponatinib for treating certain types of leukemia | Phase 2 | Houston, Texas | Recruiting | Aug 28, 2017 |
| Combining cladribine, idarubicin, cytarabine, and venetoclax for treating certain blood cancers | Phase 2 | Houston, Texas | Recruiting | Apr 16, 2014 |
All recruiting trials (4)
-
Using edetate calcium disodium or succimer to treat acute myeloid leukemia or myelodysplastic syndrome during chemotherapy
This study is testing whether two drugs, edetate calcium disodium and succimer, can safely help people with acute myeloid leukemia or myelodysplastic syndrome feel better during chemotherapy.
-
Using dexrazoxane to protect the heart during chemotherapy for blood cancers
This study is testing if a drug called dexrazoxane can help protect the hearts of people with blood cancers from damage caused by chemotherapy.
-
Combining blinatumomab, methotrexate, cytarabine, and ponatinib for treating certain types of leukemia
This study is testing a new combination of four medications to see if it can help people with certain types of leukemia that have come back or didn't respond to previous treatments.
-
Combining cladribine, idarubicin, cytarabine, and venetoclax for treating certain blood cancers
This study is testing a new combination of four medications to see if it helps people with certain types of blood cancers feel better and live longer.
Related topics
Quick answers
How many Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.